Transactions
31
Insider / JOHNSON & JOHNSON
Schmid Timothy
EVP, WW Chair, MedTech at JOHNSON & JOHNSON
- Company
- JOHNSON & JOHNSON
- Ticker
- JNJ
- First filing on record
- February 10, 2026
- Latest trade on record
- September 2, 2026
- SEC filings
- EDGAR ↗
Schmid Timothy, EVP, WW Chair, MedTech at JOHNSON & JOHNSON, has disclosed 31 transactions in JNJ since February 10, 2026: 0 purchases (0 open-market buys) and 10 sales, worth about $28.9M at the reported prices. The latest was filed September 4, 2026, 2 days after the trade; 6 filings were late against the 2-business-day Form 4 deadline.
Open-market buys
0
Sales
10
Avg. disclosure lag
2.7d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months Schmid Timothy made no purchases and 10 sales worth $18M, plus 21 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
Schmid Timothy has traded 1 stock on record; the largest by dollars is JNJ.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
1 of 5 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| M | Option exercise or conversion | 18 | 157,444 | $10.8M |
| F | Shares withheld for tax | 5 | 12,622 | $3.0M |
| S | Open-market sale | 5 | 57,542 | $15.1M |
| A | Grant or award | 3 | 42,415 | — |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 31 | 0 | 10 · $18.1M |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| JNJ | Option / conversion M | September 2, 2026 | September 4, 2026 | 2d | 22,527 | — | — | derivative | Form 4 ↗ | |
| JNJ | Option / conversion M | September 2, 2026 | September 4, 2026 | 2d | 11,070 | — | — | derivative | Form 4 ↗ | |
| JNJ | Sell S | September 2, 2026 | September 4, 2026 | 2d | 22,527 | $275 | $6.2M | Form 4 ↗ | ||
| JNJ | Option / conversion M | September 2, 2026 | September 4, 2026 | 2d | 22,527 | $151 | $3.4M | Form 4 ↗ | ||
| JNJ | Sell S | September 2, 2026 | September 4, 2026 | 2d | 11,070 | $275 | $3.0M | Form 4 ↗ | ||
| JNJ | Option / conversion M | September 2, 2026 | September 4, 2026 | 2d | 11,070 | $132 | $1.5M | Form 4 ↗ | ||
| JNJ | Sell S | February 20, 2026 | February 23, 2026 | 3d | 1,322 | $246 | $325K | Form 4 ↗ | ||
| JNJ | Option / conversion M | February 18, 2026 | February 18, 2026 | 0d | 8,998 | — | — | derivative | Form 4 ↗ | |
| JNJ | Option / conversion M | February 18, 2026 | February 18, 2026 | 0d | 13,625 | — | — | derivative | Form 4 ↗ | |
| JNJ | Other A | February 15, 2026 | February 18, 2026 | 3d | 2,548 | — | — | derivative | Form 4 ↗ | |
| JNJ | Other A | February 15, 2026 | February 18, 2026 | 3d | 35,489 | — | — | derivative | Form 4 ↗ | |
| JNJ | Option / conversion M | February 15, 2026 | February 18, 2026 | 3d | 1,026 | — | — | derivative | Form 4 ↗ | |
| JNJ | Option / conversion M | February 15, 2026 | February 18, 2026 | 3d | 1,028 | — | — | derivative | Form 4 ↗ | |
| JNJ | Option / conversion M | February 13, 2026 | February 18, 2026 | 5d | 4,378 | — | — | latederivative | Form 4 ↗ | |
| JNJ | Option / conversion M | February 13, 2026 | February 18, 2026 | 5d | 499 | — | — | latederivative | Form 4 ↗ | |
| JNJ | Sell S | February 18, 2026 | February 18, 2026 | 0d | 8,998 | $245 | $2.2M | Form 4 ↗ | ||
| JNJ | Option / conversion M | February 18, 2026 | February 18, 2026 | 0d | 8,998 | $130 | $1.2M | Form 4 ↗ | ||
| JNJ | Sell S | February 18, 2026 | February 18, 2026 | 0d | 13,625 | $244 | $3.3M | Form 4 ↗ | ||
| JNJ | Option / conversion M | February 18, 2026 | February 18, 2026 | 0d | 13,625 | $116 | $1.6M | Form 4 ↗ | ||
| JNJ | Sell F | February 15, 2026 | February 18, 2026 | 3d | 448 | $243 | $109K | Form 4 ↗ | ||
| JNJ | Option / conversion M | February 15, 2026 | February 18, 2026 | 3d | 1,026 | — | — | Form 4 ↗ | ||
| JNJ | Sell F | February 15, 2026 | February 18, 2026 | 3d | 15 | $243 | $3,652 | Form 4 ↗ | ||
| JNJ | Option / conversion M | February 15, 2026 | February 18, 2026 | 3d | 1,028 | — | — | Form 4 ↗ | ||
| JNJ | Sell F | February 13, 2026 | February 18, 2026 | 5d | 1,816 | $245 | $444K | late | Form 4 ↗ | |
| JNJ | Option / conversion M | February 13, 2026 | February 18, 2026 | 5d | 4,378 | — | — | late | Form 4 ↗ | |
| JNJ | Sell F | February 13, 2026 | February 18, 2026 | 5d | 8 | $245 | $1,956 | late | Form 4 ↗ | |
| JNJ | Option / conversion M | February 13, 2026 | February 18, 2026 | 5d | 499 | — | — | late | Form 4 ↗ | |
| JNJ | Other A | February 9, 2026 | February 11, 2026 | 2d | 4,378 | — | — | derivative | Form 4 ↗ | |
| JNJ | Option / conversion M | February 6, 2026 | February 10, 2026 | 4d | 15,571 | $102 | $1.6M | derivative | Form 4 ↗ | |
| JNJ | Sell F | February 6, 2026 | February 10, 2026 | 4d | 10,335 | $240 | $2.5M | Form 4 ↗ | ||
| JNJ | Option / conversion M | February 6, 2026 | February 10, 2026 | 4d | 15,571 | $102 | $1.6M | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| September 4, 2026 | Form 4 | 0000200406-26-000179 | 6 | published | EDGAR ↗ |
| February 23, 2026 | Form 4 | 0000200406-26-000046 | 1 | published | EDGAR ↗ |
| February 18, 2026 | Form 4 | 0000200406-26-000036 | 20 | published | EDGAR ↗ |
| February 11, 2026 | Form 4 | 0000200406-26-000026 | 1 | published | EDGAR ↗ |
| February 10, 2026 | Form 4 | 0001998491-26-000002 | 3 | published | EDGAR ↗ |
Other insiders at JOHNSON & JOHNSON
- Wolk Joseph J Exec VP, CFO 34 rows
- Broadhurst Vanessa EVP, Global Corp Affairs 25 rows
- Swanson James D. EVP, CIO 24 rows
- Wengel Kathryn E EVP, Chief TO and Risk Officer 24 rows
- Duato Joaquin CEO and Chairman of the Board 23 rows
- Taubert Jennifer L Director 23 rows
- Forminard Elizabeth EVP, Chief Legal Officer 22 rows
- REED JOHN C EVP, Innovative Medicine, R&D 21 rows
- Decker Robert J VP Corporate Controller 18 rows
- Mulholland Kristen EVP, Chief HR Officer 18 rows
Everyone on file, with contracts and lobbying under the company's name: JOHNSON & JOHNSON.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 5 | 31 | February 10, 2026 | September 4, 2026 | Form 4 list on EDGAR |
Site built October 27, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.